Tüüp : |
Ajaleht |
Interneti link : |
https://doi.org/10.1515/pthp-2020-0013 |
|
Uurimisrühmad : |
Angers - University Hospital of Angers, Pharmacy Department |
Autor : |
Lebreton V, Bourcier B, Cosson K, Lagarce F, Spiesser-Robelet L, Vrignaud S. |
Pealkiri : |
New liquid oral formulations of hydroxychloroquine: a physicochemical stability study. |
Publikatsioon : |
Pharmaceutical Technology in Hospital Pharmacy ; 6(1): 20200013. 2021 |
|
Tõendite tase : |
|
Füüsikaline stabiilsus : |
|
Keemiline püsivus : |
|
Muud meetodid : |
|
Kommentaarid : |
|
Ingredientide nimekiri
Hydroxychloroquine sulfate
|
|
|
|
|
1500 mg Plaquenil® |
SyrSpend SF PH4® |
>> 30 mL |
|
2-8°C |
|
90 |
|
|
|
|
|
|
1500 mg Plaquenil® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
2-8°C |
|
90 |
|
|
|
|
|
|
1500 mg Plaquenil® |
SyrSpend SF PH4® |
>> 30 mL |
|
28-32°C |
|
60 |
|
|
|
|
|
|
1500 mg Plaquenil® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
28-32°C |
|
90 |
|
|
|
|
|